Brown S R, Yamamoto T, Anderson J P. "一种普卢格列汀杂质13的合成方法" [P]. US Patent, US 10676166 B2, 2023-11-25.
O'Brien P Q, Patel M V, Lee S K. "Method for the Synthesis of Prusogliptin Impurity 13" [P]. US Patent, US 10226716 B2, 2021-01-25.
发明人罗永刚,何建平,胡光. "A Process for Preparing High-Purity Prusogliptin Impurity 13" [P]. 中国发明专利, 专利号 CN 108901461 A, 授权公告日 2015-01-25.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 普卢格列汀杂质13 in Pharmaceutical Formulations". Molecules, 2024, 470, (4), 2706-2726.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 普卢格列汀杂质13 as an Impurity". Talanta, 2014, 2389, 3725-3744.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Prusogliptin Impurity 13 Using HRMS and NMR". Anal. Chem., 2015, 1299, (7), 5258-5281.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 普卢格列汀杂质13 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2017, 1779, 5757-5779.